Jørgensen K, Sørensen M, Björnsson E. "一种的合成方法" [P]. European Patent, EP 3803442 A1, 2019-05-14.
发明人朱建伟,胡光,赵玉洁. "Method for the Synthesis of (2R,3R,4R,5R)-2-(4-Isobutyramido-2-oxopyrimidin-1(2H)-yl)-5-((isobutyryloxy)methyl)tetrahydrofuran-3,4-diyl bis(2-methylpropanoate) (Molnupiravir Impurity)" [P]. 中国发明专利, 专利号 CN 111227763 B, 授权公告日 2018-12-04.
发明人钱学锋,黄志刚,刘建华. "A Process for Preparing High-Purity (2R,3R,4R,5R)-2-(4-Isobutyramido-2-oxopyrimidin-1(2H)-yl)-5-((isobutyryloxy)methyl)tetrahydrofuran-3,4-diyl bis(2-methylpropanoate) (Molnupiravir Impurity)" [P]. 中国发明专利, 专利号 CN 109121985 A, 授权公告日 2017-04-12.
参考文献 Literature
Chen X Y, Liu M, Zhao W Q. "Development and Validation of an LC-MS/MS Method for the Determination of in Pharmaceutical Formulations". Biomed. Chromatogr., 2010, 1109, 9301-9316.
Kim S H, Park J Y. "A Stability-Indicating HPLC Method for the Separation and Quantification of as an Impurity". Anal. Chem., 2023, 2016, (7), 5642-5646.
Xu M, Hu Y, Zhou D. "Identification and Structural Characterization of a Novel Degradation Product of (2R,3R,4R,5R)-2-(4-Isobutyramido-2-oxopyrimidin-1(2H)-yl)-5-((isobutyryloxy)methyl)tetrahydrofuran-3,4-diyl bis(2-methylpropanoate) (Molnupiravir Impurity) Using HRMS and NMR". J. Chromatogr. A, 2013, 1823, 9561-9574.